- Home
- BEAT vs AKYA Comparison
BEAT vs AKYA Comparison
Compare BEAT & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- AKYA
- Stock Information
- Founded
- BEAT 2015
- AKYA 2015
- Country
- BEAT United States
- AKYA United States
- Employees
- BEAT N/A
- AKYA N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- AKYA Medical Specialities
- Sector
- BEAT Technology
- AKYA Industrials
- Exchange
- BEAT Nasdaq
- AKYA Nasdaq
- Market Cap
- BEAT 51.1M
- AKYA 56.1M
- IPO Year
- BEAT 2021
- AKYA 2021
- Fundamental
- Price
- BEAT $1.30
- AKYA $1.36
- Analyst Decision
- BEAT Buy
- AKYA Hold
- Analyst Count
- BEAT 1
- AKYA 7
- Target Price
- BEAT $8.00
- AKYA $2.51
- AVG Volume (30 Days)
- BEAT 169.5K
- AKYA 455.0K
- Earning Date
- BEAT 08-13-2025
- AKYA 08-04-2025
- Dividend Yield
- BEAT N/A
- AKYA N/A
- EPS Growth
- BEAT N/A
- AKYA N/A
- EPS
- BEAT N/A
- AKYA N/A
- Revenue
- BEAT N/A
- AKYA $79,961,000.00
- Revenue This Year
- BEAT N/A
- AKYA $7.26
- Revenue Next Year
- BEAT N/A
- AKYA $11.44
- P/E Ratio
- BEAT N/A
- AKYA N/A
- Revenue Growth
- BEAT N/A
- AKYA N/A
- 52 Week Low
- BEAT $1.17
- AKYA $0.93
- 52 Week High
- BEAT $3.48
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- BEAT 36.38
- AKYA 59.70
- Support Level
- BEAT $1.17
- AKYA $1.24
- Resistance Level
- BEAT $1.62
- AKYA $1.40
- Average True Range (ATR)
- BEAT 0.11
- AKYA 0.08
- MACD
- BEAT -0.02
- AKYA 0.01
- Stochastic Oscillator
- BEAT 21.96
- AKYA 90.24
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.